Tuesday, February 5, 2019

“Lucrative Asian Markets to Offer Significant Growth Opportunities for the Chromatography Instruments Market in the Coming Years”


Chromatography Instruments Market – {By System [LC (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, Detectors, Fraction Collectors)], By Consumable (Reverse Phase Columns, Syringe Filters, Vials)} - Analysis & Global Forecasts to 2022.

Chromatography is versatile analytical technique used to separate a mixture into its individual components. Thus, chromatography is extensively used by pharmaceutical and biotechnology companies in drug discovery and development, in environment and food & beverage testing, and among others. Depending on the sample to be analyzed, liquid chromatography (LC), gas chromatography (GC), supercritical fluid chromatography (SFC), and thin-layer chromatography (TLC) techniques are predominantly used.  

                            
Growth in the chromatography instruments market is likely to be centered in the Asia-Pacific region. Growth in Asia-Pacific can be attributed to government investments in biomedical industry in China, strategic expansions of chromatography players in China, increasing focus on soil testing in India, food security concerns in India, and presence of bioclusters in India and China.

The key industry players like Bruker Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Shimadzu Corporation (Japan) are establishing their presence in China by establishing new facilities, R&D centers, and innovation centers in the country. Apart from this, the government investment in the Chinese biomedical industry that comprises biological drugs, medical equipment & materials, and bioagriculture has propelled the market for chromatography instrumentation. In addition, the development of innovation cluster named BioBay (China) that is focused on increasing R&D activities among emerging biological and nanotechnology companies is bolstering the market for chromatography instrumentation in China. 

 

The free trade agreement between Korea and the U.S. increased opportunities to import medical and research equipment into Korea. The strong shipping and air cargo infrastructure in Korea further accelerates the movement of goods and services. Furthermore, in January 2013, the European Union (EU) announced that by July 2013, drugs, active pharmaceutical ingredients (APIs), and excipients exported by New Zealand and Australia should comply with the standards equivalent to the European Good Manufacturing Practice (GMP). This step would ensure that the drugs exported by these countries need not go through additional quality checks in Europe, thus eliminating delays in their export. The increase in exports will increase the demand for chromatography instruments required in the Quality Assurance (QA) and Quality Control (QC) of these drugs.

No comments:

Post a Comment

Pharmaceutical Filtration Market: Recent Trends and Developments

  Growth in the pharmaceutical filtration market can be attributed to factors such as rapid growth in the R&D and manufacturing of bioph...